Avenue Therapeutics Inc (ATXI)

[Monksdream]

ATXI new 52 week low

[Monksdream]

ATXI new 52 week low

[Monksdream]

ATXI new 52 week low

[Monksdream]

ATXI new 52 week low

[Monksdream]

ATXI new 52 week low

[Monksdream]

ATXI new 52 week low

[Monksdream]

ATXI new 52 week low

[subslover]

Just caught this.
FDA Meeting with Avenue Therapeutics to Discuss Study Protocol for IV Tramadol and Respiratory Depression Risk
https://beststocks.com/fda-meeting-with-avenue-therapeutics-to-discu/

[Rocketred]

Avenue Therapeutics initiated by Aegis at buy. $32.00 PT. $ATXI

[Rocketred]

GET YOUR CHEAP SHARES before they are gone for APRIL ATXI

APRIL 2023 FDA approval = The FDA stated that the proposed study design appears reasonable and agreed on various study design aspects with the expectation that additional feedback would be provided to Avenue upon review of a more detailed study protocol.

[glenn1919]

ATXI.......................https://stockcharts.com/h-sc/ui?s=ATXI&p=W&b=5&g=0&id=p86431144783

[81vette]

perfect load and hold for pop,30% win,my scanner is fine tuned,only took 20 years to perfect,lol

[tw0122]

Premarket up..

Avenue Therapeutics Provides Regulatory Update on IV Tramadol and Other Corporate Updates

Source: GlobeNewswire Inc.

Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of rare and neurologic diseases, today announced that it will participate in a Type C meeting with the FDA on March 9, 2023 to discuss a proposed study protocol to assess the risk of respiratory depression related to opioid stacking on intravenous tramadol (“IV Tramadol”) relative to an approved opioid analgesic. The Company expects to provide an update on the outcome of the meeting in April 2023, after receipt of the meeting minutes from the FDA.
As disclosed in September 2022, Avenue received meeting minutes from the FDA regarding a Type A meeting conducted on August 9, 2022, for IV Tramadol. At the meeting, Avenue presented a study design for a single safety clinical trial that the Company believes could address the concerns regarding risks related to opioid stacking and the FDA stated that the proposed study design appeared reasonable and agreed on various study design aspects with the expectation that additional feedback would be provided to Avenue upon review of a more detailed study protocol.

Subsequent to the August 9 meeting, the Company incorporated the FDA’s suggestions from the meeting minutes and submitted a Type C Meeting Request and a briefing book that included a detailed study protocol for further discussion with the FDA.

[81vette]

Very Little supply until $1.50 might be a two ticket ride soon

[81vette]

Looks like our last ticker that went up 80% AH ,institutes move tickers,retail not much,follow the big money for big moves

[81vette]

11mms demand now,macd crossed to bulls,wont be long now

[81vette]

expect headline news "THINKING ABOUT BUYING ATXI"in next few days (common with this many Xs above ave. volume,propels pps up hundreds of % higher)

[81vette]

news also expected >IV Tramadol, which is in Phase 3 clinical development for the management of moderate-to-moderately-severe pain in adults<this will be even bigger news,(way more profit and to market or buyout sooner)

[81vette]

granted Orphan Drug Designation (“ODD”) by the U.S. Food and Drug Administration for the indications of SBMA, Huntington’s Disease and Spinocerebellar Ataxia.no cure or therapy exists(ATXI will be first and only,institutions desire that)

[81vette]

i am buying 1.08 now,ppl with 20k/200k+ followers are loading and will start promoting,only a matter of time,carbon copy lately,beautiful low risk high reward/fomo greed is how to play mkt

[81vette]

watch for demand to find bottom,10k@ 1.06 is building,lately 12mms stacked on green bid is bottom,currently 4 (watch for that to build up over11mms)demand will come as float is getting accumulated right now,supply will run out today or tomorrow just like the last huge runners lately,piece of cake now

[81vette]

just like the other winners,300% to 1000% possible here,with 2 past $15 runs on chart,greed is strong here,another no brainer low risk high reward

[81vette]

$5m traded so far,57Xs ave vol,scanners blowing up and ATXI getting found

[81vette]

another zero borrow/not optionable,short squeeze,huge winner coming here!!!!

[HoldEm777]

Today may have started Round 2

[HoldEm777]

Is it time yet? lol. In then out then back in. Seems to be showing more signs of life again today.

[HoldEm777]

Is it time yet? lol. In then out then back in. Seems to be showing more signs of life again today.

[Soulman856]

$ATXI —— Avenue Therapeutics Inc

?? 12 million offering is closed!

?? ATXI used to buy back share!

??Filings out this week showing this and. 6.6% insider buy!

?? 3 million float with 64% short!

?? pending approval from FDA expected soon!

??changes sent to FDA in august.

?? on FINTEL short squeeze Report????

Moves fast!

[TheFinalCD]

Oct 04 2022 14.50 2.99 25.98% 14.92 16.65 12.54 10,429,254
Oct 03 2022 11.51 1.43 14.19% 13.96 15.51 11.35 16,021,386
Sep 30 2022 10.08 2.83 39.03% 7.26 12.31 7.25 27,368,871
Sep 29 2022 7.25 0.80 12.4% 6.60 8.38 6.33 8,605,198
Sep 28 2022 6.45 -0.81 -11.16% 6.11 7.9299 6.05 4,876,001
Sep 27 2022 7.26 3.74 106.25% 5.77 11.12 5.56 58,517,200

https://ih.advfn.com/stock-market/NASDAQ/avenue-therapeutics-ATXI/historical

[TheFinalCD]

LOL oh yeah I lost on that one too

[layton]

LOL. I thought you said VYST. That was the FAIL of them all!!!!!

[Soulman856]

$ATXI
Believe we should have an update on approval and time now! With all the insider Buyer, per the 13Gs just release. IT MOST BE VERY VERY CLOSE

Also,just put the 8K out that they are now complaint with Nasdaq!!!

$Avenue Therapeutics Inc
Avenue received the official meeting minutes from the FDA regarding a meeting conducted on August 9, 2022, for IV Tramadol.

The Company intends to incorporate the FDA’s suggestions from the meeting minutes and submit a detailed study protocol that could form the basis for the submission of a complete response to the second Complete Response Letter for IV Tramadol.

[Soulman856]

Running today?

[Soulman856]

He it goes!!!

[doogdilinger]

Agreed Gold buddy, lookin' forward to ridin' alongside the big boys here:)

[doogdilinger]

Hey VST brotha always great to arrive on the same table with ya! Hope you've been well:)

[doogdilinger]

Ding ding ding ding ding>>>Another for the winners circle subs buddy>>>$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

[bowlfan912]

Yessum

[Soulman856]

Is it running?

[subslover]

Strap yourself in. This is a rocket flight!

[bowlfan912]

Here we go!

[Soulman856]

I’m can you translate this post? Going to $8 or nah

[VST7]

Doog's on this train..$7-$8.Bux a-comin..Heard-it on.the track...

[Spicknspan]

Would wait for news on their clinical trials. jmo

[bowlfan912]

Hope so, I bought at 3.66 this morning.

$ATXI 13G filed - CVI Investments, Inc. takes 272,700 shares a 6.6% stake https://t.co/PtE0LPKcxH pic.twitter.com/qv69563Zsv

— Moon Market (@MoonMarket_) October 17, 2022

[Soulman856]

Moving up again! Something big coming here. A lot of buying. Inflow is trumping out

[Gizzer211]

Had some news release earlier

[Bronk]

When will this ticker stop being a dump fest? I want to buy in for another run but looking like it’s going to be awhile

[Soulman856]

Whoa, ATXI is ripping it today. 1 million float and 70% is shorted?!?!

[Go-Gold]

GM, Doog ! Holding until at least $7.71 , that’s the pps the company paid for 388,888shares. Should get there from here?